UNSPSC 51143207: Lobeline

This classification denotes a nicotinic agonist with the molecular formula C22H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0P25S3P81, chemically known as 8,10-diphenyllobelionol but generally known as lobeline, which bears US NIH Compound Identifier 3945. European Medicines Agency schedules Lobeline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08541MIG. The term LOBELINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18).

UNSPSC 51143207 Lobeline is a Commodity code under which state and local governments purchase pharmaceutical products and related drug intervention systems, though recent activity in this code shows minimal direct alignment with the lobeline product itself. The solicitations tagged to this code actually reflect procurement of naloxone (an opioid overdose reversal agent) and drug deactivation systems for public health response, as well as exploratory contracting for direct-to-manufacturer prescription fulfillment models. The issuing bodies include county health departments and state health and human services agencies executing public health initiatives and pharmacy benefit programs. Seminole County, Florida and the Texas Health and Human Services Commission represent the mix of regional and state-level buyers conducting recent procurement activity under this classification.

Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2026 response deadline, with quarterly deliveries to the Seminole County Community Health Building and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs that bypass traditional pharmacy benefit managers and wholesalers, signaling exploratory interest in alternative pharmaceutical distribution models for state employee and retiree health plans. The code shows activity concentrated in the Southeast and South, though the geographic footprint is narrow; the mismatch between the Commodity code name (Lobeline) and the actual pharmaceutical procurement (naloxone and pharmacy distribution) suggests either tagging error or broader categorization of alkaloid-derived pharmaceutical interventions within this classification.